Cargando…

Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

Detalles Bibliográficos
Autores principales: Costello, Ruth E, Humphreys, Jenny H, Winthrop, Kevin L, Dixon, William G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677482/
https://www.ncbi.nlm.nih.gov/pubmed/32591355
http://dx.doi.org/10.1136/annrheumdis-2020-217255
_version_ 1783611983694659584
author Costello, Ruth E
Humphreys, Jenny H
Winthrop, Kevin L
Dixon, William G
author_facet Costello, Ruth E
Humphreys, Jenny H
Winthrop, Kevin L
Dixon, William G
author_sort Costello, Ruth E
collection PubMed
description
format Online
Article
Text
id pubmed-7677482
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-76774822020-11-30 Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis Costello, Ruth E Humphreys, Jenny H Winthrop, Kevin L Dixon, William G Ann Rheum Dis Letter BMJ Publishing Group 2020-12 2020-06-26 /pmc/articles/PMC7677482/ /pubmed/32591355 http://dx.doi.org/10.1136/annrheumdis-2020-217255 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter
Costello, Ruth E
Humphreys, Jenny H
Winthrop, Kevin L
Dixon, William G
Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
title Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
title_full Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
title_fullStr Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
title_full_unstemmed Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
title_short Pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
title_sort pneumonia vaccination timing in relation to starting conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677482/
https://www.ncbi.nlm.nih.gov/pubmed/32591355
http://dx.doi.org/10.1136/annrheumdis-2020-217255
work_keys_str_mv AT costelloruthe pneumoniavaccinationtiminginrelationtostartingconventionalsyntheticdiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritis
AT humphreysjennyh pneumoniavaccinationtiminginrelationtostartingconventionalsyntheticdiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritis
AT winthropkevinl pneumoniavaccinationtiminginrelationtostartingconventionalsyntheticdiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritis
AT dixonwilliamg pneumoniavaccinationtiminginrelationtostartingconventionalsyntheticdiseasemodifyingantirheumaticdrugsinpatientswithrheumatoidarthritis